Experimental drug aims to help people with rare nerve disease

NCT ID NCT06537999

Recruiting now Disease control Sponsor: Dianthus Therapeutics Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an experimental drug called DNTH103 is safe and effective for adults with multifocal motor neuropathy (MMN), a rare condition that causes muscle weakness. The trial will involve 36 participants who are already receiving standard immunoglobulin treatment. Researchers will compare DNTH103 against a placebo to see if it helps maintain strength and delays the need for additional immunoglobulin treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Clinical Study Site
RECRUITING

Scottsdale, Arizona, 85251, United States
Clinical Study Site
RECRUITING

Los Angeles, California, 90048, United States
Clinical Study Site
RECRUITING

Bradenton, Florida, 34205, United States
Clinical Study Site
RECRUITING

Tampa, Florida, 33620, United States
Clinical Study Site
RECRUITING

Honolulu, Hawaii, 96817, United States
Clinical Study Site
RECRUITING

Kansas City, Kansas, 66103, United States
Clinical Study Site
RECRUITING

Chapel Hill, North Carolina, 27599, United States
Clinical Study Site
RECRUITING

Cincinnati, Ohio, 45219, United States
Clinical Study Site
RECRUITING

Columbus, Ohio, 43210, United States
Clinical Study Site
RECRUITING

Houston, Texas, 77030, United States
Clinical Study Site
RECRUITING

Aarhus, 8200, Denmark
Clinical Study Site
RECRUITING

Copenhagen, 1172, Denmark
Clinical Study Site
RECRUITING

Marseille, 13005, France
Clinical Study Site
RECRUITING

Paris, 94000, France
Clinical Study Site
RECRUITING

Rome, 00189, Italy
Clinical Study Site
RECRUITING

Amsterdam, 1105, Netherlands
Clinical Study Site
RECRUITING

Utrecht, Netherlands
Clinical Study Site
RECRUITING

Skopje, North Macedonia
Clinical Study Site
RECRUITING

Bydgoszcz, 85-090, Poland
Clinical Study Site
RECRUITING

Katowice, 40-689, Poland
Clinical Study Site
RECRUITING

Krakow, 30-688, Poland
Clinical Study Site
RECRUITING

Krakow, 31-202, Poland
Clinical Study Site
RECRUITING

Belgrade, 11000, Serbia
Clinical Study Site
RECRUITING

Barcelona, 08035, Spain
Clinical Study Site
RECRUITING

London, England, United Kingdom
Clinical Study Site
RECRUITING

Oxford, England, United Kingdom

Conditions

Explore the condition pages connected to this study.

MULTIFOCAL MOTOR NEUROPATHY